At this conference we focus on initiatives in academia and industry and the need for collaboration as well as framework conditions needed to put research to use for the benefit of patients and society.
Programme
08:00–08:30 Registration and breakfast
Place: Area outside Forum auditorium
08:30–10:00 Impact Breakfast: Antimicrobial resistance – a global challenge with urgent need for new solutions
Place: Area outside Forum auditorium
- Welcome to Science Impact 2025
Hilde Nebb, Professor, innovation director, UiO Growth House - Global and national perspectives – what has been, what is and what will be?
Kristian Tonby, MD, PhD, associate professor, Institute of Clinical Medicine, UiO and Oslo OUS - New therapy against drug-resistant tuberculosis
Tone T?njum, Professor, Institute of Clinical Medicine, UiO and OUS - What does it take to develop a new antibiotic? – from bioprospecting to AI-supported identification
Geir Klinkenberg, research manager, SINTEF - Inventing and developing novel resistance breakers
P?l Rongved, CSO, AdjuTec Pharma AS and professor emeritus, Department of Pharmacy, UiO - Development of new antibiotics from the perspectives of a large pharmaceutical company
Kristin L?seth, medical director Norway, AstraZeneca - Developing diagnostic device to detect drug resistant bacteria
Elizaveta Vereshchagina, PhD, senior research scientist, SINTEF - Precision-guided missiles to target harmful bacteria
Jukka Corander, Institute of Basic Medical Sciences, UiO
10:00–10:30 Networking
10:30–12:00 Parallel sessions
Cancer treatment – Oslo a world-leading hub for radiopharmacy
Place: Forum auditorium
- Theranostics – targeted radionuclide therapy
Mona Elisabeth Rootwelt-Revheim, MD, PhD, professor II, head of The Intervention Centre, UiO and OUS - Building competence and infrastructure on radionuclides
Sunniva Siem, professor Department of Physics UiO, and centre director, the Norwegian Nuclear Research Centre - Transforming cancer through direct alpha therapy
?ystein Soug, CEO, Oncoinvent -
Challenging cancer indications met with challenging technology
Speaker TBA, ARTBIO - Development of radionuclides from the perspectives of a large pharmaceutical company
Jenny Karlsson, senior director targeted radiopharmaceuticals, Bayer
Materials science advancing medical research and development
Place: Toppsenteret
- New technology for precision human tissue and modeling of neurodegenerative diseases
Joel Glover, professor, Institute of Basic Medical Sciences, UiO, Kaja Nordengen, MD, Phd, senior physician, OUS and Michal Mielnik, research manager, SINTEF - PharmaChip: Robust, automated, and sustainable chemical analysis of organoids and organ-on-chip systems
Steven Ray Wilson, professor, Department of Chemistry, UiO and Fr?ydis Sved Skottvoll, PhD, research scientist, SINTEF - Towards more flexible, biocompatible and less invasive brain implants
Florian Dapsance, PhD candidate, Department of Physics, UiO - BreathSense – transforming COPD patient care with ground-breaking hand-held breath diagnostics sensor technology
Elizaveta Vereshchagina, PhD, senior research scientist, SINTEF
Speakers from companies to come.
12:00–13:00 Networking and lunch
Place: Area outside Forum auditorium and Toppsenteret
13:00–14:30 Parallel sessions
Neuroscience – better diagnosis and treatment of Alzheimer's, Parkinson's and multiple sclerosis
Place: Forum auditorium
- Global and national perspectives on a growing challenge – what has been, what is and what will be?
Geir Selb?k, MD, PhD, professor II, Institute of Clinical Medicine, UiO, and research director, The Norwegian National Centre for Ageing and Health - Modeling brain disease using organoids,
Magnar Bj?r?s, PhD, researcher, Institute of Clinical Medicine, UiO and OUS and professor, NTNU - Therapeutic trials and vaccine studies in multiple sclerosis (MS)
Gro Owren Nygaard, MD, PhD, researcher, Institute of Clinical Medicine, UiO and OUS - Research and development in the field of neurodegenerative disorders in a large pharmaceutical company
Susanne Fabre, PhD, senior director translational biomarkers and bioanalysis, BioArctic - Personalized neuro diagnostics with AI
Per Wessel Nore, CEO, baba - Deep brain stimulation therapy for Parkinson's
J?rn Thomas Waagb?, therapy specialist, Medtronic - Next generation biomarkers for neurodegenerative diseases
Speaker TBA, Pre Diagnostics
Social innovation
Place: Toppsenteret
- Markus Bugge, associate professor, Taran Thune, professor, and Magnus Gulbrandsen, professor, TIK Centre for Technology, Innovation and Culture, UiO
- Speakers from projects in SPARK Social Innovation and more to come
14:30–15:00 Networking
Place: Area outside Forum auditorium and Toppsenteret
15:00–16:30 Impact Afternoon: Women's health research and development
Place: Forum auditorium
- Imaging pregnancies with new AI-technologies
Anne Eskild, MD, PhD, professor II, Institute of Clinical Medicine, UiO and Akershus University Hospital (Ahus) - Developing new methods to diagnose and treat endometriosis
Hanne Haslene-Hox, PhD, senior research scientist, SINTEF - Bed-side test to determine fertile days and improve IVF outcome
Peter Fedorcsak, MD, PhD, professor II, Institute of Clinical Medicine, UiO and OUS - New therapy against breast cancer
Esmaeil Dorraji, PhD, CSO and founder, Immunoquest Therapeutics AS - Gender differences in stroke
Vilde Teigene M?l?y, PhD candidate, UiO, OUS and The Norwegian Air Ambulance Foundation - R&D on women's health in a large pharmaceutical company
Speaker TBA, Bayer
16:30–17:00 Networking with refreshments
Place: Area outside Forum auditorium
Organisers
Main organiser: UiO Growth House
Internal partners at the University of Oslo (UiO): Faculty of Medicine, Faculty of Mathematics and Natural Sciences, Centre for Global Sustainability, Department of Informatics, Centre for Materials Science and Nanotechnology and SPARK Social Innovation
External partners: Inven2, SINTEF, The Life Science Cluster, Nansen Neuroscience Network, Oslo Cancer Cluster, LMI, Oslo University Hospital (OUS), Oslo Science City and Oslo Science Park
Questions?
Please contact the UiO Growth House, Norunn K. Torheim, Head of communications and public and external relations, at norunnt@uio.no
See the programme and pictures from Science Impact 2024 and Science Impact 2023.